Literature DB >> 9822227

A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers.

J Youn1, T A Cox, L W Herndon, R R Allingham, M B Shields.   

Abstract

PURPOSE: To compare the efficacy of transscleral cyclophotocoagulation using a neodymium: YAG (Nd:YAG) or semiconductor diode laser in controlling intraocular pressure in patients with refractory glaucoma.
METHODS: In a prospective study, 95 eyes of 91 patients with refractory glaucoma randomly received Nd:YAG or diode cyclophotocoagulation. Patients were followed for a mean of 10.4 months (10.42 +/- 3.16, mean +/- SD). We compared available data preoperatively and at 1 week, 1 month, 6 months, and 12 months postoperatively. Data analyzed were corrected visual acuity, intraocular pressure, and the type of glaucoma.
RESULTS: There was a statistically significant decrease in intraocular pressure after both Nd:YAG and diode cyclophotocoagulation at each time period. However, there were no significant differences in postoperative intraocular pressure or visual acuity change between Nd:YAG and diode procedures.
CONCLUSIONS: Compared with the Nd:YAG laser for transscleral cyclophotocoagulation, the diode laser has technological advantages including portability, durability, and smaller size, while providing equivalent postoperative intraocular pressure and visual acuity change.

Entities:  

Mesh:

Year:  1998        PMID: 9822227     DOI: 10.1016/s0002-9394(98)00228-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  [Endocyclophotocoagulation for the treatment of glaucoma].

Authors:  M Neuburger; D Böhringer; J F Jordan
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

2.  Cyclodestructive procedures for refractory glaucoma.

Authors:  Monica F Chen; Carole H Kim; Anne L Coleman
Journal:  Cochrane Database Syst Rev       Date:  2019-03-10

3.  Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome.

Authors:  Patty Lin; Gadi Wollstein; Ioannis P Glavas; Joel S Schuman
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

4.  Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.

Authors:  T Schlote; M Derse; M Zierhut
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

5.  Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma.

Authors:  M E Iliev; S Gerber
Journal:  Br J Ophthalmol       Date:  2007-05-10       Impact factor: 4.638

6.  Cyclophotocoagulation and cyclocryocoagulation as primary surgical procedures for open-angle glaucoma.

Authors:  Isabel Gorsler; Hagen Thieme; Christian Meltendorf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-04       Impact factor: 3.117

7.  Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation.

Authors:  S C Lin; M J Chen; M S Lin; E Howes; R L Stamper
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

8.  Trans-scleral diode laser cyclophotocoagulation for refractory glaucoma after high-risk penetrating keratoplasty.

Authors:  Alejandro Rodríguez-García; Luis Alonso González-González; J Carlos Alvarez-Guzmán
Journal:  Int Ophthalmol       Date:  2015-09-29       Impact factor: 2.031

9.  Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliatve glaucoma. Long-term clinical outcomes.

Authors:  Matthias Grueb; Jens Martin Rohrbach; Karl Ulrich Bartz-Schmidt; Torsten Schlote
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-21       Impact factor: 3.117

10.  Clinical options for the reduction of elevated intraocular pressure.

Authors:  Laura Crawley; Sohaib M Zamir; Maria F Cordeiro; Li Guo
Journal:  Ophthalmol Eye Dis       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.